FIND

Status: Active Trial | Marker: FGFR Title A phase II trial to evaluate efficacy and safety of erdafitinib in patients with advanced squamous NSCLC (sqNSCLC) harboring FGFR genetic alterations after relapse of standard therapy. Study Number EudraCT 2018-000399-13...